Table 2.
Antibodies used in the present study
| Antibody against | Clone | Dilution | Antigen retrieval method | Source |
|---|---|---|---|---|
| CD3 | LN10 | 1:100 | HIER | Novocastra Laboratories, Newcastle upon Tyne, UK |
| CD5 | 4C7 | 1:50 | HIER | Dako, Glostrup, Denmark |
| CD10 | 56C6 | 1:100 | HIER | Novocastra Laboratories, Newcastle upon Tyne, UK |
| CD20 | L26 | prediluted | HIER | Ventana Medical Systems, Tucson, Arizona, USA |
| bcl-2 | 124 | prediluted | HIER | Ventana Medical Systems, Tucson, Arizona, USA |
| bcl-6 | LN22 | 1:40 | HIER | Novocastra Laboratories, Newcastle upon Tyne, UK |
| MUM-1 | MUM1p | 1:50 | HIER | Dako, Glostrup, Denmark |
| Cyclin D1 | SP4-R | prediluted | HIER | Ventana Medical Systems, Tucson, Arizona, USA |
| TdT | SEN28 | prediluted | HIER | Nichirei Biosciences, Tokyo, Japan |
| Ki-67 | MIB-1 | 1:100 | HIER | Dako, Glostrup, Denmark |
HIER: heat-induced epitope retrieval.